Dopamine DA 1 Receptor Agonist Activity of YM435 in the Canine Renal Vasculature

By Yatsu T.   Uchida W.   Inagaki O.   Tanaka A.   Takenaka T.  

General Pharmacology, Vol. 29, Iss. 2, 1997-08 ,pp. : 229-232

Elsevier

Access to resources Recommend Favorite

Renal effect of YM435, a new dopamine D 1 receptor agonist, in anesthetized dogs

By Yatsu T.   Arai Y.   Takizawa K.   Kasai-Nakagawa C.   Takanashi M.   Uchida W.   Inagaki O.   Tanaka A.   Asano M.   Honda K.   Takenaka T.  

European Journal of Pharmacology, Vol. 322, Iss. 1, 1997-03 ,pp. : 45-53

Elsevier

Access to resources Recommend Favorite

Preventive effect of zelandopam, a dopamine D1 receptor agonist, on cisplatin-induced acute renal failure in rats

By Yatsu T.   Aoki M.   Inagaki O.  

European Journal of Pharmacology, Vol. 461, Iss. 2, 2003-02 ,pp. : 191-195

Elsevier

Access to resources Recommend Favorite

The dopamine receptor agonist Z1046 reduces ischaemia severity in a canine model of coronary artery occlusion

By Vegh A.   Papp J.G.   Semeraro C.   Fatehi-Hasanabad Z.   Parratt J.R.  

European Journal of Pharmacology, Vol. 344, Iss. 2, 1998-03 ,pp. : 203-213

Elsevier

Access to resources Recommend Favorite

Effects of YM 435 and A 77636 on Dopamine D-1 Receptors in Bovine Retina In Vitro

By Ofori S.   De Raad S.   Bugnon O.   Schorderet M.  

General Pharmacology, Vol. 26, Iss. 1, 1995-01 ,pp. : 51-57

Elsevier

Access to resources Recommend Favorite